ArticleAmerican journal of translational research2023
Difference in oral microbiota composition between patients with stage 5 chronic kidney disease on hemodialysis and healthy controls.
Article in American journal of translational research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 3 citations in OpenAlex.
- Association of periodontitis with reduced kidney function and albuminuria in early chronic kidney disease: a population-based study.International journal of oral science · 2026Article
- Article
- Causal association between oral microbiome and chronic kidney disease: two-sample Mendelian randomization.Archives of medical science : AMS · 2026Article
- Characteristics of tongue coating microbiota in diabetic and non-diabetic kidney patients receiving hemodialysis.BMC oral health · 2025Article
- Salivary microbiome in peritoneal dialysis patients with and without sarcopenia: A pilot study.PloS one · 2025Article
- Uremic Stomatitis: A Latin American Case Series and Literature Review.Head and neck pathology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Owing to the symbiotic relationship between the microbiota and the human body, the microbiome is considered a "second human genome". Microorganisms are inextricably associated with human diseases and can affect the host phenotype. In the present study, 25 female patients with stage 5 chronic kidney disease (CKD5) undergoing hemodialysis in our hospital and 25 healthy subjects were recruited. The structure of the oral microbiota of the study participants was analyzed using the MiSeq PE300 sequencing platform and high-throughput 16S rDNA sequencing. The microbiota was compared between the groups using QIIME and the stats package in R. In total, 1,336 operational taxonomic units (OTUs) were obtained, and the relative frequencies of 450 OTUs differed significantly between the two groups (P < 0.05), indicating that the samples were rich in OTUs. A comparison of β-diversity indicated a significant difference in the microbial community structure between the two groups (P < 0.05). These results indicated that the biological diversity of the oral microbiota was highly correlated with CKD5. In this experiment, 189 genera, with significant differences in abundance between the groups (P < 0.05), were found. Furthermore, differences in the structure of the oral microbiota were observed between the groups at the phylum, class, order, family, and genus levels. Collectively, an imbalance in the oral microbiota may accelerate the progression of CKD and cause additional complications.
Indexed as
Identifiers
37303656PMC10250997W4380291369What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.